HCV Group Evaluation and Treatment Uptake (HCV GET-UP) Intervention

Completed · Not applicable

Conditions studied: Hepatitis C, Substance Use Disorders

In brief

People who inject drugs (PWID) represent the overwhelming majority of both HCV and HIV/HCV infected people in the United States. Though new, direct-acting HCV medications are highly efficacious and have the potential to end the HCV epidemic, few PWIDs ever initiate treatment. This study seeks to improve HCV treatment uptake and cure among HCV and HIV/HCV+ PWIDs by testing a primary care based HCV Group Evaluation and Treatment UPtake (GET-UP) intervention. If efficacious, this innovative care intervention could provide a means to reduce the growing mortality from HCV, as well as decrease the current reservoir for HCV transmission.

Key facts

Study ID

NCT03242655

Run by

Montefiore Medical Center

People needed

96

Starts

2017-02-21

Expected to finish

2020-10-30

Last updated by the study team

2021-03-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• HCV Ab+ with detectable HCV viral load
• greater than fifth grade reading level
• English proficiency
• current or former IDUs
• willingness to be randomized to a group intervention.

You may not qualify if…

• short life-expectancy, such that HCV treatment would not be beneficial (e.g. end-stage cancer)
• decompensated liver disease

Where it is running

• Comprehensive Health Care Center — The Bronx, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.